Key Drivers
- Strong liquidity
- Improving margins
- Rich valuation
AIAI Summary
ATRC now looks like a legitimate profitability and free-cash-flow inflection story rather than just a procedural-growth bet, but with the stock near highs and valuation already assuming continued margin expansion, the key takeaway is to watch whether this improved execution can persist across several quarters before adding aggressively.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Strong liquidity
- •Improving margins
- •Rich valuation
ATRC has strong liquidity, improving quarterly profitability, and healthy cash flow, but its annual earnings remain inconsistent, stock-based compensation is heavy, and the valuation is demanding relative to current profit power.
Price Behavior
Key Price Behavior Insights:
- •Breakout held
- •Higher highs
- •Stretch risk
Over the last month, ATRC broke above $39.0-$40.2, made higher highs and higher lows to fresh highs, and remains bullish but stretched, with support near $41.4-$41.6 and $39.0-$39.5.
Fast rally from $34.95 to $44.30 suggests near-term volatility risk
Sentiment & News
Key News Insights:
- •Revenue acceleration
- •Profitability return
- •Insider selling
AtriCure is showing strong operating momentum, with double-digit revenue growth, a Q2 GAAP profit beat, and expanding procedure adoption, though minimally invasive ablation weakness and recent insider selling temper the outlook.
The news is broadly positive for AtriCure's growth story, but investors may stay cautious until weaker segments and insider activity settle
Similar Companies in Healthcare
Other companies in the same sector with AI ratings